Nevada

0 clinical studies

Back to Search

Las Vegas, Nevada

Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Recruiting Now

Interventional • Run by Allergan

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Phase 2

Las Vegas, Nevada

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Recruiting Now

Interventional • Run by Biohaven Pharmaceutical Holding Company Ltd.

Migraine

Phase 2/3

Las Vegas, Nevada

Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

Recruiting Now

Interventional • Run by Lumos Labs, Inc.

ADHD

N/A

Reno, Nevada

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Recruiting Now

Interventional • Run by Amgen

Atherosclerotic Cardiovascular Disease

N/A

Las Vegas, Nevada

Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

Recruiting Now

Interventional • Run by AEON Biopharma, Inc.

Migraine

Phase 2

Las Vegas, Nevada

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Recruiting Now

Interventional • Run by UCB Biopharma SRL

Early-stage Parkinson's Disease

Phase 2

Reno, Nevada

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)

Recruiting Now

Interventional • Run by Arcutis Biotherapeutics, Inc.

Atopic Dermatitis Eczema

Phase 3

Las Vegas, Nevada

A Study of LY3209590 Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Recruiting Now

Interventional • Run by Eli Lilly and Company

Type 1 Diabetes

All Conditions(2)

Phase 3

Las Vegas, Nevada

Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

Recruiting Now

Interventional • Run by Aptinyx

PTSD

Phase 2/3

Las Vegas, Nevada

A Study of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Recruiting Now

Interventional • Run by Eli Lilly and Company

Type 2 Diabetes

All Conditions(2)

Phase 3

See all top locations